p53	O
-	O
dependent	O
expression	O
of	O
CXCR5	O
chemokine	O
receptor	O
in	O
MCF	O
-	O
7	O
breast	O
cancer	O
cells	O
.	O


Elevated	O
expression	O
of	O
chemokine	O
receptors	O
in	O
tumors	O
has	O
been	O
reported	O
in	O
many	O
instances	O
and	O
is	O
related	O
to	O
a	O
number	O
of	O
survival	O
advantages	O
for	O
tumor	O
cells	O
including	O
abnormal	O
activation	O
of	O
prosurvival	O
intracellular	O
pathways	O
.	O


In	O
this	O
work	O
we	O
demonstrated	O
an	O
inverse	O
correlation	O
between	O
expression	O
levels	O
of	O
p53	O
tumor	O
suppressor	O
and	O
CXCR5	O
chemokine	O
receptor	O
in	O
MCF	O
-	O
7	O
human	O
breast	O
cancer	O
cell	O
line	O
.	O


Lentiviral	O
transduction	O
of	O
MCF	O
-	O
7	O
cells	O
with	O
p53	O
shRNA	O
led	O
to	O
elevated	O
CXCR5	O
at	O
both	O
mRNA	O
and	O
protein	O
levels	O
.	O


Functional	O
activity	O
of	O
CXCR5	O
in	O
p53	O
-	O
knockdown	O
MCF	O
-	O
7	O
cells	O
was	O
also	O
increased	O
as	O
shown	O
by	O
activation	O
of	O
target	O
gene	O
expression	O
and	O
chemotaxis	O
in	O
response	O
to	O
B	O
-	O
lymphocyte	O
chemoattractant	O
CXCL13	O
.	O


Using	O
deletion	O
analysis	O
and	O
site	O
-	O
directed	O
mutagenesis	O
of	O
the	O
cxcr5	O
gene	O
promoter	O
and	O
enhancer	O
elements	O
,	O
we	O
demonstrated	O
that	O
p53	O
appears	O
to	O
act	O
upon	O
cxcr5	O
promoter	O
indirectly	O
,	O
by	O
repressing	O
the	O
activity	O
of	O
NFkappaB	O
transcription	O
factors	O
.	O


Using	O
chromatin	O
immunoprecipitation	O
and	O
reporter	O
gene	O
analysis	O
,	O
we	O
further	O
demonstrated	O
that	O
p65	O
/	O
RelA	O
was	O
able	O
to	O
bind	O
the	O
cxcr5	O
promoter	O
in	O
p53	O
-	O
dependent	O
manner	O
and	O
to	O
directly	O
transactivate	O
it	O
when	O
overexpressed	O
.	O


Through	O
the	O
described	O
mechanism	O
,	O
elevated	O
CXCR5	O
expression	O
may	O
contribute	O
to	O
abnormal	O
cell	O
survival	O
and	O
migration	O
in	O
breast	O
tumors	O
that	O
lack	O
functional	O
p53	O
.	O
